COVID-19 and Cancer: Otis Brawley, MD on the Future of the Pandemic
Last week, NCCS hosted a conversation with cancer control expert and epidemiologist Otis Brawley, MD. NCCS CEO Shelley Fuld Nasso moderated the discussion. “We knew exactly who we wanted to be our first guest speaker in this series. Dr. Otis Brawley is a Bloomberg Distinguished Professor at Johns Hopkins University, ...
NCCS Joins Statement of Support for COVID-19 Vaccination of All Health Care Workers
NCCS joined other patient, professional, and research organizations of the Cancer Leadership Council (CLC) in issuing a statement in support of COVID-19 vaccination of all health care workers. The emergence of the highly contagious Delta variant, which is now sweeping through unvaccinated Americans across the country, creates serious problems for ...
NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers
The National Coalition for Cancer Survivorship (NCCS) and the Cancer Leadership Council (CLC) sent a letter to the CDC's Advisory Committee on Immunization Practices (ACIP) to recommend actions to accelerate the vaccination of cancer survivors, who are at risk of poor outcomes from COVID-19. Cancer patients have been confronted by ...
NCCS Urges CDC Committee to Include Cancer Survivors in High-Risk Category for COVID-19 Vaccine Distribution
In a letter to the CDC’s Advisory Committee on Immunization Practices (ACIP), NCCS urged the committee to review the data related to the risks that COVID-19 poses to cancer survivors as they monitor and update the immunization schedule and evaluate states’ flexible use of the schedule. There are serious risks ...
